Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Private equity stories

Nov 11, 2026

Pfizer secures up to $1.5 billion from Blackstone for obesity drug development

Pfizer has struck a deal with Blackstone to receive up to $1.5 billion through 2028 to fund development of an experimental monthly obesity treatment, as the company races to compete in the GLP-1 market without a currently approved weight-loss drug.

Nov 11, 2026·3 sources
00
Nov 6, 2026

New CMS rule ties Medicare billing privileges to owner conduct

CMS finalized a rule targeting Medicare providers owned by companies with violations in other programs, requiring reenrollment for home health and other providers based on owners' misconduct records.

Nov 6, 2026·2 sources
00
Nov 5, 2026

CMS ousts two No Surprises Act arbitrators amid impartiality concerns

The Trump administration denied recertification to two arbitration firms — Island Peer Review Organization and Network Medical Review Company — that adjudicate payment disputes under the No Surprises Act.

Nov 5, 2026·2 sources
00
Oct 25, 2026

Bon Secours nears $6 billion takeover of Bain-backed Surgery Partners

Non-profit health system Bon Secours Mercy Health is in late-stage talks to acquire a majority stake in Surgery Partners, valuing the Bain Capital-backed surgical care provider at approximately $6 billion including debt.

Oct 25, 2026·3 sources
00
Oct 21, 2026

EQT agrees to acquire Qiagen in major diagnostics takeover

Swedish private equity firm EQT has agreed to acquire Dutch molecular testing company Qiagen for approximately €9.6 billion ($10.8 billion) in an all-cash voluntary public takeover offer at €46.50 per share, representing a 40.3% premium to the unaffected share price. The deal ends years of takeover speculation surrounding the diagnostics firm.

Oct 21, 2026·4 sources
00
Oct 7, 2026

Weston family to buy Boots pharmacy chain for $8.9 billion

Canada's Weston family, through holding company Wittington Investments, has agreed to acquire Britain's Boots pharmacy and beauty retail chain from Sycamore Partners and the Pessina family for $8.9 billion. The deal includes Boots' retail operations in the U.K. and Ireland, Boots Opticians, and the No7 Beauty Co.

Oct 7, 2026·9 sources
00
Aug 12, 2026

OpenAI-backed Thrive Holdings raises $2 billion at $12 billion valuation

Thrive Holdings has secured $2 billion in new funding at a $12 billion valuation from investors including SoftBank, D1 Capital Partners, and Altimeter Capital. The company operates as a private equity firm focused on bringing AI solutions to enterprise clients.

Aug 12, 2026·2 sources
00
Aug 6, 2026

KKR Acquires Medicover India's 24-Hospital Network for $1.3 Billion

Global investment firm KKR has signed a definitive agreement to acquire Medicover India, the Indian hospital business of Stockholm-based Medicover, in a deal valued at approximately $1.3 billion (₹10,000-14,250 crore). The acquisition marks KKR's largest healthcare deal in India and includes a 24-hospital network, with plans for additional investment of ₹3,000-4,000 crore for expansion.

Aug 6, 2026·7 sources
00
Aug 3, 2026

Curium to take radiopharma company Lantheus private in $8 billion deal

Nuclear medicine company Curium has struck a deal to take Lantheus Holdings Inc. private in a transaction worth approximately $8 billion.

Aug 3, 2026·2 sources
00
Jul 15, 2026

Stripe and Advent International Make $53 Billion Takeover Offer for PayPal

Payment processor Stripe and private equity firm Advent International have jointly offered to acquire PayPal Holdings for $60.50 per share, valuing the deal at approximately $53 billion. PayPal's stock surged 14-15% following the news.

Jul 15, 2026·7 sources
00

Top claims

  • ▪In 2024, Blackstone Inc. reached an agreement to fund trials for Moderna Inc.’s influenza vaccine, which subsequently received U.S. regulatory approval in summer 2026
  • ▪Pfizer Inc. will maintain full ownership and operational control over the clinical development program for berobenatide under its funding deal with Blackstone Inc.
  • ▪Blackstone Inc. has expanded its involvement in co-funding clinical drug development trials in recent years

Subtopics

Mergers & acquisitions (M&A)6Healthcare industry4Corporate consolidation2Healthcare Access and Insurance2Pharma2Pharmaceutical Industry2Trump administration2AI startups1Business & enterprise AI1Clinical trials1Conflicts of interest1Corporate strategy1Cross-border healthcare1Diagnostic medicine1Drug Approval and Clinical Trials1Drug development1Drug Policy, Pricing & Approval1Fintech1GLP-11GLP-1 receptor agonists1Health insurance1Healthcare costs1Healthcare fraud1Healthcare providers1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories